PRESS RELEASE published on 07/09/2024 at 12:30, 1 year 9 months ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Immunic appoints Jason Tardio as Chief Operating Officer and President, bringing extensive multiple sclerosis drug commercialization experience. Werner Gladdines promoted to Chief Development Officer Chief Operating Officer Multiple Sclerosis Immunic Jason Tardio Werner Gladdines
BRIEF published on 05/28/2024 at 12:35, 1 year 11 months ago Immunic to Participate in Industry and Scientific Conferences in June Biotechnology Investor Relations Conférences Chronic Diseases Scientific Engagement
BRIEF published on 05/28/2024 at 12:35, 1 year 11 months ago Immunic participera à des conférences industrielles et scientifiques en juin Biotechnologie Conférences Relations Avec Les Investisseurs Maladies Chroniques Engagement Scientifique
PRESS RELEASE published on 05/28/2024 at 12:30, 1 year 11 months ago Immunic to Participate in Industry and Scientific Conferences in June Immunic, Inc. (Nasdaq: IMUX) will participate in BIO International Convention 2024 and PCMG Assembly 2024 in June to present clinical pipeline of therapies for chronic inflammatory and autoimmune diseases Clinical Pipeline Immunic Inc IMUX BIO International Convention 2024 PCMG Assembly 2024
BRIEF published on 05/08/2024 at 12:35, 1 year 11 months ago Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
BRIEF published on 05/08/2024 at 12:35, 1 year 11 months ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 11 months ago Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update Immunic, Inc. reports first quarter 2024 financial results, including capital increase and progress in MS and gastrointestinal disease therapies Financial Results Clinical Trials Immunic Inc. Gastrointestinal Disease MS Therapy
BRIEF published on 05/06/2024 at 12:35, 1 year 11 months ago Immunic AG Announces Participation in May Conferences for Investor and Scientific Communities Investor Conferences Clinical Trials Immunic AG Scientific Conferences Autoimmune Disease Treatments
BRIEF published on 05/06/2024 at 12:35, 1 year 11 months ago Immunic AG annonce sa participation aux conférences de mai destinées aux communautés d'investisseurs et scientifiques Essais Cliniques Conférences Investisseurs Immunic SA Conférences Scientifiques Traitements Des Maladies Auto-immunes
PRESS RELEASE published on 05/06/2024 at 12:30, 1 year 11 months ago Immunic to Participate in Investor and Scientific Conferences in May Immunic, Inc. to participate in investor and scientific conferences in May, presenting clinical trial data on oral therapies for inflammatory diseases Investor Conferences Clinical Trials Immunic Inc. Inflammatory Diseases Scientific Conferences
Published on 05/06/2026 at 09:01, 2 hours 43 minutes ago Apex Widens and Extends Newly Discovered Zone with Significant NdPr Enrichment (>30%)
Published on 05/06/2026 at 02:17, 9 hours 27 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 9 hours 44 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 9 hours 44 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 11:38, 6 minutes ago Drägerwerk AG & Co. KGaA: No vote on items 7 and 8 of the agenda at the Annual Shareholders’ Meeting on May 8, 2026 - Cancellation of the separate meeting of preferred shareholders
Published on 05/06/2026 at 10:45, 59 minutes ago Thailand Approves $29 Billion Investment Wave as Data Center Demand Surges
Published on 05/06/2026 at 10:00, 1 hour 44 minutes ago 2026 Pacific Ocean International Festival of Rock Balancing and Arts Holds Grand Opening at Qixingtan Scenic Area on May 1st
Published on 05/06/2026 at 10:00, 1 hour 44 minutes ago Mallia Therapeutics Announces Publication and Congress Presentation on Accelerated Wound Healing with sCD83
Published on 05/06/2026 at 10:00, 1 hour 44 minutes ago MAKTEK Eurasia 2026 positions Türkiye as a manufacturing hub
Published on 05/06/2026 at 11:36, 7 minutes ago Nombre total de droits de vote et d'actions composant le capital social
Published on 05/06/2026 at 10:09, 1 hour 35 minutes ago Guillemot Corporation : Information regarding the total number of voting rights and shares 30/04/2026
Published on 05/06/2026 at 10:09, 1 hour 35 minutes ago Guillemot Corporation : Informations relatives au nombre total de droits de vote et d’actions 30/04/2026
Published on 05/06/2026 at 09:09, 2 hours 35 minutes ago Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 05/06/2026 at 08:42, 3 hours 2 minutes ago Disclosure of shares outstanding and voting rights - 06.05.2026
